Skip to main content
Premium Trial:

Request an Annual Quote

Igenbio, Genome Compiler Team to Create Synthetic Bio Solutions

NEW YORK (GenomeWeb) – Genome analysis firm Igenbio said today it has struck a collaborative agreement with the synthetic biology software design firm Genome Compiler to develop new solutions targeting the synthetic biology community.

The partners will use Chicago-based Igenbio's ERGO genome and analysis discovery system and Genome Compiler's proprietary biology designs solution. ERGO is a web-based platform that integrates functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with other information in the public sphere.

Genome Compiler, based in Los Angeles, provides a software platform for bio-engineering and genomic manipulation tools.

"Partnering with Genome Compiler to create a single integrated platform providing exceptional annotations, pathways, and an enormous curated parts database across all genomes will enable scientists to expedite new product creation," Igenbio's President and CEO Vinayak Kapatral said in a statement.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.